IP Library Granted Patent US 7,075,658
Granted Patent B2
US 7,075,658 · App. 10/765,010 · Granted Jul 11, 2006

Method for optical coherence tomography imaging with molecular contrast

Assignees: Duke University; Case Western Reserve University
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,075,658
App. No.
10/765,010
Granted
Jul 11, 2006
Kind
B2
Abstract

Spatial information, such as concentration and displacement, about a specific molecular contrast agent, may be determined by stimulating a sample containing the agent, thereby altering an optical property of the agent. A plurality of optical coherence tomography (OCT) images may be acquired, at least some of which are acquired at different stimulus intensities. The acquired images are used to profile the molecular contrast agent concentration distribution of the sample.

Claims (15)

1. A method of determining spatial information about specific molecular contrast agents in a sample comprising the steps of:

(a) stimulating, at a plurality of intensity levels, the sample thereby altering an optical property of the molecular contrast agent;

(b) acquiring a plurality of optical coherence tomography (OCT) images, at least some of the plurality of OCT images being acquired at different stimulus intensities; and

(c) profiling the molecular contrast agent concentration distribution based on the plurality of OCT images.

2. The method of claim 1 , wherein the stimulation intensity levels provide transient changes in the optical property of the molecular contrast agent.

3. The method of claim 1 , wherein at least some of the stimulation intensity levels provide saturation of the optical property of the molecular contrast agent.

4. The method of claim 1 , wherein stimulating the molecular contrast agent increases the optical absorption of the agent.

5. The method of claim 1 , wherein stimulating the molecular contrast agent increases the optical transparency of the agent.

6. The method of claim 1 , wherein stimulating the sample is performed using light at one wavelength and acquiring the images is performed using light at another wavelength.

7. The method of claim 1 , wherein stimulating the sample is performed using light at the same wavelength as the light used for acquiring the images.

8. The method of claim 7 , wherein the phase of light used for stimulating the sample is different that the phase of light used for acquiring the images.

9. The method of claim 1 , wherein acquiring the images is performed after stimulating the sample.

10. The method of claim 1 , wherein acquiring the images is performed while stimulating the sample.

11. The method of claim 1 , wherein profiling the molecular contrast agent concentration includes comparing OCT images acquired with the stimulation source active to those acquired with the stimulation source inactive.

12. The method of claim 1 , wherein profiling the molecular contrast agent concentration includes comparing OCT images acquired at different intensities of stimulation.

Assignments (1)
CONFIRMATORY LICENSE Recorded Feb 10, 2020
From: DUKE UNIVERSITY
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 051867/0769 →
Continuity (2)
Provisional Application 6044205400 · Jan 24, 2003
Related Publication 20050036150A1 · Feb 17, 2005